Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Oncotarget
|
July 2, 2014
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
Leonel Maldonado, Mariana Brait, Christina Michailidi, et al.
Urology
|
November 22, 2011
Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum
Phillip M Pierorazio, Thomas J Guzzo, Misop Han, et al.
Oncotarget
|
May 17, 2014
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
Masamichi Hayashi, Heike Bernert, Luciane Tsukamoto Kagohara, et al.
Urology
|
March 31, 2010
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen
Phillip M Pierorazio, Thomas J Guzzo, Misop Han, et al.
The Journal of Urology
|
March 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Journal of the National Cancer Institute
|
July 20, 2006
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque, Shahnaz Begum, Ozlem Topaloglu, et al.
The Journal of Urology
|
April 29, 2026
Reply by Authors
Sandip M Prasad, Dimitar Shishkov, Nikola V Mihaylov, et al.
Plos One
|
November 25, 2015
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Alexander S Baras, Nilay Gandhi, Enrico Munari, et al.
The Journal of Urology
|
December 18, 2007
Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer
Mohammad Obaidul Hoque, Shahnaz Begum, Mariana Brait, et al.
Plos One
|
August 1, 2015
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Alexander S Baras, Nilay Gandhi, Enrico Munari, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Oncotarget
|
July 2, 2014
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
Leonel Maldonado, Mariana Brait, Christina Michailidi, et al.
Urology
|
November 22, 2011
Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum
Phillip M Pierorazio, Thomas J Guzzo, Misop Han, et al.
Oncotarget
|
May 17, 2014
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
Masamichi Hayashi, Heike Bernert, Luciane Tsukamoto Kagohara, et al.
Urology
|
March 31, 2010
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen
Phillip M Pierorazio, Thomas J Guzzo, Misop Han, et al.
The Journal of Urology
|
March 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Journal of the National Cancer Institute
|
July 20, 2006
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque, Shahnaz Begum, Ozlem Topaloglu, et al.
The Journal of Urology
|
April 29, 2026
Reply by Authors
Sandip M Prasad, Dimitar Shishkov, Nikola V Mihaylov, et al.
Plos One
|
November 25, 2015
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Alexander S Baras, Nilay Gandhi, Enrico Munari, et al.
The Journal of Urology
|
December 18, 2007
Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer
Mohammad Obaidul Hoque, Shahnaz Begum, Mariana Brait, et al.
Plos One
|
August 1, 2015
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Alexander S Baras, Nilay Gandhi, Enrico Munari, et al.
Page
of 7